Shree Cement Q1 Profit Drops; Black Rose, Tamboli Shine

The June 2026 quarter presented a varied landscape for Indian companies, with Shree Cement reporting a significant dip in net profit, while other firms like Black Rose Industries and Tamboli Industries showcased robust growth.

Separately, corporate developments propelled shares of Ishan Dyes and Chemicals and Fischer Medical Ventures higher, reflecting targeted advancements and strategic partnerships.

Mixed Quarterly Performance

Shree Cement recorded a 29.19% decline in net profit for the June 2026 quarter, even as its revenue base expanded.

• Revenue increased by 13.64% to Rs 56,226.80 million, up from Rs 49,479.80 million year-over-year.
• Net profit decreased to Rs 4,379.90 million from Rs 6,185.10 million.
• Operating profit also saw a reduction, falling to Rs 12,758.50 million from Rs 14,301.20 million.

Conversely, Black Rose Industries demonstrated strong performance, with both sales and net profit seeing substantial increases during the same quarter.

• Sales vaulted by 48.84% to Rs 890.81 million, compared to Rs 598.50 million in the previous year.
• Net profit soared by 145.22% to Rs 104.07 million from Rs 42.44 million.
• Operating profit for the quarter stood at Rs 154.41 million.

Tamboli Industries also delivered robust growth figures for the June 2026 quarter, marked by a significant surge in total revenue.

• Its revenue rose 8.28% to Rs 3.14 million from Rs 2.90 million.
• Total revenue expanded by an impressive 329.41% to Rs 0.73 million from Rs 0.17 million.
• Operating profit increased to Rs 1.10 million from Rs 0.72 million.

Corporate Developments Drive Share Gains

Ishan Dyes and Chemicals experienced a notable share surge following an announcement regarding new production initiatives.

• Shares zoomed 8.33% to Rs 55.25.
• The company initiated production activities for four new Sulphur-Based products.
• Commercial launch of these products is anticipated within the next three months, signaling a capacity expansion.

Fischer Medical Ventures also saw its shares rise after revealing a strategic partnership by one of its arms.

• Shares increased by 2.24% to Rs 39.68.
• Its arm partnered with Parul Sevashram Hospital to install the DRIS–iMRI Medharanya Suite.
• This system is an AI-enabled, next-generation portable intraoperative MRI.

The quarter underscored a diverse corporate environment where established players faced profit pressures while niche companies capitalized on growth opportunities and strategic advancements.